EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Cia-Hin Lau iD, Qing-Le Liang iD, Haibao Zhu iD

Transgenic Research · 2024-10 · 33 (5) · 323-357

DOI: 10.1007/s11248-024-00404-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transgenic Research, online erschienen am 19.08.2024. Verfasst von Cia-Hin Lau und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Shantou University, Shantou, 515063, Guangdong, China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Epigenome, Mitochondria. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 314 Literaturangaben. Gefördert von: Xiamen Municipal Bureau of Science and Technology-National Foreign Expert Program, Shantou University Research Initiation Fund Project, Guangdong Provincial Natural Science Foundation General Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The application of rapidly growing CRISPR toolboxes and methods has great potential to transform biomedical research. Here, we provide a snapshot of up-to-date CRISPR toolboxes, then critically discuss the promises and hurdles associated with CRISPR-based nuclear genome editing, epigenome editing, and mitochondrial editing. The technical challenges and key solutions to realize epigenome editing in vivo, in vivo base editing and prime editing, mitochondrial editing in complex tissues and animals, and CRISPR-associated transposases and integrases in targeted genomic integration of very large DNA payloads are discussed. Lastly, we discuss the latest situation of the CRISPR/Cas9 clinical trials and provide perspectives on CRISPR-based gene therapy. Apart from technical shortcomings, ethical and societal considerations for CRISPR applications in human therapeutics and research are extensively highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsEpigenomeMitochondriaHumansAnimalsGenetic TherapyClustered Regularly Interspaced Short Palindromic RepeatsGenome

Stichwörter der Autor:innen

Base editorCRISPREpigenome editingGenome editingIntegraseMitochondrial editingPrime editorTransposase

Autor:innen und Institutionen

  • Department of Biology, College of Science, Shantou University, Shantou, 515063, Guangdong, China.
  • Department of Clinical Laboratory Medicine, Chongqing University Jiangjin Hospital, Chongqing, China.
  • Department of Biology, College of Science, Shantou University, Shantou, 515063, Guangdong, China. zhuhaibao@stu.edu.cn.

ORCID-Profile: Cia-Hin Lau, Qing-Le Liang, Haibao Zhu

Förderung

  • Xiamen Municipal Bureau of Science and Technology-National Foreign Expert Program
  • Shantou University Research Initiation Fund Project
  • Guangdong Provincial Natural Science Foundation General Project

Zitieren

APA

Lau, C. H., Liang, Q. L., & Zhu, H. (2024). Next-generation CRISPR technology for genome, epigenome and mitochondrial editing. Transgenic Research, 33(5), 323-357. https://doi.org/10.1007/s11248-024-00404-x

Vancouver

Lau CH, Liang QL, Zhu H. Next-generation CRISPR technology for genome, epigenome and mitochondrial editing. Transgenic Research. 2024;33(5):323-357. doi:10.1007/s11248-024-00404-x

BibTeX
@article{Lau2024,
  author = {Lau, Cia-Hin and Liang, Qing-Le and Zhu, Haibao},
  title = {Next-generation CRISPR technology for genome, epigenome and mitochondrial editing},
  journal = {Transgenic Research},
  year = {2024},
  volume = {33},
  number = {5},
  pages = {323--357},
  doi = {10.1007/s11248-024-00404-x}
}
Kostenlos starten →